Session handouts and meetings archive

Handouts ... 2025 Innovation Academy, Chicago, IL, July 10-13 2025 Annual Meeting, Orlando, FL, March 7-11 2024 Innovation Academy, Seattle, WA, August 1-4 2024 Annual Meeting, San Diego, CA, March 8-12 2023 Innovation Academy, Tampa, FL, August 10-13 2023 Annual Meeting, New Orleans, LA, March 17-21 Sessions ... 2025 Innovation

CME & session evaluation archive

Claim CME & submit session evaluations ... Claim CME credit and submit session evaluations for attending previous Academy meetings: ... 2025 Innovation Academy, Chicago, IL, July 10-13 2025 Annual Meeting, Orlando, FL, March 7-11 2024 Innovation Academy, Seattle, WA, August 1-4 2024 Annual Meeting, San Diego, CA, March 8-12 2023

Reflections on vacation and terrorism impacting continuing medical education

By Warren R. Heymann, MD Aug. 18, 2016 What impacts your life, either personally or professionally? What external factors influence what we learn and how we practice? ... This commentary was composed over the Atlantic Ocean, returning from a cruise sponsored by the Alabama Dermatology Society. For anyone who has

AADA hosts largest Capitol Hill skin cancer check in a decade

On May 15, the AADA hosted its 10th annual Capitol Hill Skin Cancer Check and Health Fair with the Congressional Skin Cancer Caucus. This event was our largest to date, hosting 198 Hill staffers and 11 members of Congress, performing 127 skin checks, and providing 75 Reveal camera image results.

PDF of AADA support letter

Honorable Lisa Murkowski The Honorable Tom Udall Chairman Ranking Member Subcommittee on Interior

IA25 Meeting Suites Guidelines

charge to be billed directly through Freeman: • exterior graphic panel to the right of the door • Interior

2025 AAD Annual Meeting | Exhibitor Meeting Suites Guidelines

to be billed directly through Freeman: • (1) exterior graphic panel to the right of the door • Interior

2026 AAD Annual Meeting | Exhibitor Meeting Suites Guidelines

to be billed directly through Freeman: • (1) Exterior graphic panel to the right of the door • Interior

AAD Event Advertising: Annual Meeting

The Academy's Annual scientific meeting offers unprecedented access to thousands of dermatologists attending high-profile continuing medical education events. ... For exhibitors looking to promote their products and services, build booth traffic, and facilitate face-to-face discussions, the Academy offers a wide selection of high-impact advertising opportunities. Look here for advertising opportunities

PS-Joint Position Statement on Buffered Lidocaine

Non-sterile powder-free gloves 5 Pate DA, Shimizu I, Akin R, Snodgrass K, Emrick A.

PDF of Nominating Committee Member Rep. Regional Map

the PE WEST REGION OF THE UNITED STATES QC ON AND CANADIAN PROVINCES ONLY NS (Shown in Pink) ND WA

PDF of Board of Directors Regional Map

NL 9 BC 40 NL AB SK MB 9 47 4 12 PE QC 1 ON 64 NS 140 20 WA ND MT NB 333 46 22

Academy physician leaders meet with federal legislators

On June 4, AADA physician leaders met with legislators in Washington, D.C., as part of the House Call on the Mall fundraiser hosted by the National Republican Congressional Committee and Rep. John Joyce, MD, FAAD (R-PA). During the event, AADA leaders reiterated the importance of Medicare physician payment reform. ...

2025 AAD Annual Meeting Global Education Day | International Psoriasis Council Agenda

MPH – University of California Los Angeles, Los Angeles, California, United States Jaquelini Barboza da

2025 AAD Innovation Academy Attendee Statistics

Innovation Academy Attendance over the years: 2024 – Seattle, WA ..................................

International Psoriasis Council agenda

FMedSci – University of Manchester, Manchester, United Kingdom CASE PRESENTERS Jaquelini Barboza da

AADA hosts 10th annual Capitol Hill Skin Cancer Check and Health Fair

Moving the needle ... By Apoorva Stull, Senior Manager, Advocacy Communications, May 1, 2024 DermWorld ... breaks down the latest highlights of AADA advocacy activities at the federal and state legislative and regulatory level. On May 15, the AADA hosted its 10th annual Capitol Hill Skin Cancer Check and Health

2024 AAD Innovation Academy | Official exhibitor suppliers

Experient) is the official housing provider for the 2024 AAD Innovation Academy Meeting in Seattle, WA

Medical research funding

Ask the Expert ... By Victoria Houghton, managing editor, August 1, 2021 DermWorld ... spoke to Jennifer Mangone, JD, manager of congressional policy for the American Academy of Dermatology Association (AADA), about the Academy’s advocacy efforts to support medical research funding. DermWorld: Advocating for medical research funding is a top

Becoming pro-geriatric by understanding progeria

By Warren R. Heymann, MD Aug. 13, 2018 A fifteen-year-old boy with Hutchinson-Gilford progeria syndrome. ... Credit: ... JAAD I have never seen a case of Hutchinson-Gilford progeria syndrome (HGPS). You probably haven’t either, given its incidence of 1 in 4 million. Why comment on a disease that will likely

Propranolol and neutrophilic dermatoses: Can beta-blockade be better blockade?

By Warren R. Heymann, MD, FAAD December 8, 2021 Vol. 3, No. 48 Ask any dermatology resident what the first-line treatment is for infantile hemangiomas (IH) and you will get a matter-of-fact response — "propranolol" — as if this has been an entrenched fact for decades. Barely more than a

PDF of BF transplant dermatology

Am J Transplant. 2017 Nov;17(11):2782-2789. doi: 10.1111/ajt.14337. Epub 2017 May 30.

Weighing in on glucagon-like peptide-1 receptor agonists in dermatology

By Warren R. Heymann, MD, FAAD April 17, 2024 Vol. 6, No. 16 Glucagon-like peptide-1 (GLP-1) receptor agonists — your patients are on them, and perhaps you are too (or at least have thought about it). In 2023, more than 500 million people worldwide were afflicted with obesity and type

Advocacy Update Feb. 4 2025

IN THIS ISSUE / Feb. 4, 2025 Physician champions introduce Medicare physician payment fix in House Academy joins coalition urging less regulatory burdens in Medicare Advantage and Part D program AADA urges CMS to improve MVP framework Become an AADA Advocacy Key Contact Support dermatology champions in Congress through SkinPAC

Exchanging plasma exchange for a novel approach: The potential of FcRn antagonists in dermatologic autoimmune disease

By Warren R. Heymann, MD, FAAD Nov. 1, 2023 Vol. 5, No. 44 Pemphigus vulgaris (PV) and pemphigus foliaceus (PF) are potentially life-threatening disorders demanding aggressive therapy with all the finesse and skill that dermatologists can muster. PV is characterized by IgG autoantibodies targeting desmoglein (Dsg)‐3, which is associated with

Rounds on pityriasis rotunda

By Warren R. Heymann, MD, FAAD Aug. 7, 2024 Vol. 6, No. 32 Science, medicine, and patient strife aside, sometimes I just admire the beauty of skin lesions in and of themselves. Round, annular, and targetoid lesions (fixed drug eruptions, granuloma annulare, tinea, subacute lupus, erythema multiforme, erythema migrans, and

Advocacy Update Dec 9, 2025

IN THIS ISSUE / Dec. 9, 2025 AADA endorses annual inflationary update to Medicare payment legislation Upcoming formulary prior authorization changes to Blue Cross Blue Shield’s federal employee coverage Podcast highlights advocacy on dermatopathology payer and regulatory challenges AMA offering $1 million in community health program grants Peter Friedman, MD,

Taking the challenge: Social media, adolescents, and the skin

By Albert C. Yan, MD June 12, 2019 Vol. 1, No. 14 Patterned skin injury can raise the specter of non-accidental trauma. However, over the past decade or so, striking examples of patterned skin injury have emerged among adolescents and pre-teens that share certain features: these are self-induced voluntarily; the

A single case report has the potential to change the world: Could JAK inhibition alter the trajectory of multicentric reticulohistiocytosis?

By Warren R. Heymann, MD, FAAD July 20, 2022 Vol. 4, No. 29 One of the joys of practicing in the Delaware Valley is participating in the Philadelphia Dermatological Society (PDS). The local institutions each provide superlative patient presentations and lectures — the range of case presentations is stunning. For

Advocacy Update Feb. 18 2025

IN THIS ISSUE / Feb. 18, 2025 AADA, house of medicine demand reversal of Medicare cut and provide a pay boost AADA highlights need for Medicare physician payment reform at House Committee on Ways and Means hearing Dermatology addresses new CLIA requirements for lab directors Legislators reject pharmacists’ effort to

Advocacy Update Mar. 18, 2025

IN THIS ISSUE / Mar. 18, 2025 AADA outraged that Congress passed government funding without doc fix AADA advocates for dermatologists in CLIA lab director requirements FDA testing confirms minimal benzene in most benzoyl peroxide acne products, some voluntary recalls issued Add your voice and become an AADA Advocacy Key

Mentorship mentation: Bringing out the best of us!

By David A. Wetter, MD Sept. 9, 2020 Vol. 2, No. 36 I have been experiencing sports withdrawal during this COVID-19 life pause. I even (excitedly) gobbled up the recently televised NBA HORSE competition. Currently my family and I are enjoying ESPN’s 10-hour documentary ... The Last Dance , which

Exploring the gamut of monoclonal gammopathy of cutaneous significance

By David A. Wetter, MD, FAAD Sept. 17, 2025 Vol. 7, No. 37 One of our favorite board-review books during my dermatology residency was ... Dermatology Quick Glance , authored by Drs. Saeed Jaffer and Abrar Qureshi in 2004. My coresidents and I would periodically meet during the few months

Surviving and thriving after a natural disaster

Answers in Practice ... By Emily Margosian, Assistant Editor, September 1, 2023 DermWorld ... talks to Mary Lupo, MD, FAAD, from the Lupo Center for Aesthetic and General Dermatology in New Orleans, about how to prepare your practice for a natural disaster. Mary Lupo, MD, FAAD ... DermWorld: Tell us

Unrestricted fascination with restrictive dermopathy

By Warren R. Heymann, MD, FAAD Nov. 16, 2022 Vol. 4, No. 46 Barely a week into our fellowships at the University of Pennsylvania in 1984, my wife (a geneticist) asked her favorite dermatologist (me) if I had any thoughts about a neonate with skin that was thin, taut, and

PDF of Histiocytosis

Kornik RI, Naik HB, Lee CC, Estrada-Veras J, Gahl WA, Cowen EW.

Glucose monitors: Not as sweet as they seem

By Christen M. Mowad, MD Oct. 9, 2019 Vol. 1, No. 31 ... The next contact allergen of the year has been announced early by the American Contact Dermatitis Society and it is an acrylate, isobornyl acrylate. (1) This chemical is a photopolymerizable monomer that has been used in industrial

A seasoned approach to treating the “salt and pepper” dyspigmentation of systemic sclerosis

By Warren R. Heymann, MD, FAAD Feb. 1, 2023 Vol. 5, No. 5 It only takes a nanosecond for a dermatologist to recognize the "salt and pepper" dyspigmentation (SPD) of systemic sclerosis (SSc), but a lifetime to understand and manage it. Of all the cutaneous signs of SSc (sclerodactyly, telangiectasias,

Dermatologists should not be in the dark about kratom

By Warren R. Heymann, MD, FAAD Oct. 11, 2023 Vol. 5, No. 41 Dermatological sleuthing mandates an ever-expanding knowledge database. The correct diagnosis may prove elusive if you do not know the right questions to ask. Astute clinicians have a differential diagnosis of cutaneous and/or mucosal hyperpigmentation, including heavy metal

Researching therapeutic reformation of the capillary malformation: Arteriovenous Malformation Syndrome

By Warren R. Heymann, MD June 17, 2020 Vol. 2, No. 24 Small cutaneous lesions may have profound systemic implications. Astute dermatologists will recognize these lesions and assess patients accordingly, often to the surprise of referring physicians and patients alike. ... The Capillary Malformation – Arteriovenous Malformation (CM-AVM) syndrome was

Sebaceous carcinoma — Double trouble

By Warren R. Heymann, MD, FAAD July 23, 2025 Vol. 7, No. 29 Sebaceous carcinoma (SC, aka sebaceous gland carcinoma) is double trouble — the cancer itself and its potential association with the Muir-Torre syndrome (MTS). ... SC is an aggressive malignancy that develops from the sebaceous glands. SC is

Taking it on the shin: Part one

By Warren R. Heymann, MD, FAAD May 31, 2023 Vol. 5, No. 22 I am intentionally skeptical of medical literature that purports "new" entities. Are they novel and distinct or just minor variations of long-recognized dermatoses? This two-part commentary will focus on two disorders that involve the pretibial region —

Softening the blow of calcinosis cutis: The promise of intralesional sodium thiosulfate

By Warren R. Heymann, MD Oct. 12, 2017 ... Calcinosis cutis and pseudoxanthoma elasticum of central abdomen. Firm, erythematous nodules with focal areas of yellow chalky material centrally. ... Credit: ... JAAD I’m not sure what’s harder about calcinosis cutis (CC), the lesion itself or treating it. ... Calcinosis cutis

A seasoned approach to treating the “salt and pepper” dyspigmentation of systemic sclerosis

By Ashley Decker, MD, FAAD, and Naomi Lawrence, MD, FAAD Feb. 8, 2023 Vol. 5, No. 6 Ashley Decker, MD, FAAD ... Naomi Lawrence, MD, FAAD ... A commonly held belief in dermatologic surgery is that second intention wounds have a lower risk of surgical site infection (SSI) than primary

Going green: The complexities of the green nail syndrome

By Warren R. Heymann, MD February 3, 2021 Vol. 3, No. 5 I find a unique satisfaction in diagnosing the green nail syndrome (GNS, aka chloronychia, Goldman-Fox syndrome) — it is easy to recognize and very reassuring to patients who were convinced they had a subungual melanoma. Based on new

2020 Legislative Conference Overview of Asks

Suzan DelBene, D-WA, Mike Kelly, R-PA, Ami Bera, MD, D-CA, and Roger Marshall, MD, R-KS.

Key messages to communicate about Indoor tanning

Key messages ... Using indoor tanning beds can increase your risk of skin cancer, including melanoma, the deadliest form of skin cancer. (1-15) ... Using tanning beds before age 20 can increase your chances of developing melanoma by 47%, and the risk increases with each use. (16) ... Women younger

CXCR4 antagonist therapy based on a WHIM syndrome

By Warren R. Heymann, MD, FAAD June 12, 2024 Vol. 6, No. 24 Emelio* had a delightfully whimsical personality that matched his syndrome’s acronym — WHIM ( ... W arts, ... H ypogammaglobulinemia, ... I nfections, and ... M yelokathexis). His smile was as infectious as his verrucae, and he

Key messages for social media about hair loss

Key messages ... Many conditions and diseases can result in hair loss, as can improper hair care. ... The most common cause of hair loss is hereditary thinning or baldness, also known as androgenetic alopecia. (1) This condition affects an estimated 80 million Americans — 50 million men and 30

Men in the Twilight Zoon

By Warren R. Heymann, MD February 19, 2020 Vol. 2, No. 7 It is a dimension as vast as space and as timeless as infinity. It is the middle ground between light and shadow, between science and superstition, and it lies between the pit of man's fears and the summit

2024 AAD Annual Meeting Sponsorship Prospectus

sponsorships are also available for the 2024 AAD Innovation Academy (formerly Summer Meeting) in Seattle, WA

Breaking the terbinafine laboratory habit for onychomycosis

By Warren R. Heymann, MD May 22, 2019 Vol. 1, No. 11 ... Are you a creature of habit when it comes checking laboratory tests for certain prescriptions? I am. I get nervous if the quantiferon TB test is not checked annually for patients on biologics. If my patient is

PS-Hidradenitis Suppurativa

Kimball AB, Okun MM, Williams DA, et al.

Biotin supplementation for hair and nail health: Does it pass the test?

By Warren R. Heymann, MD, FAAD November 17, 2021 Vol. 3, No. 46 When patients ask me about biotin supplementation for their hair or nails, the usual question is what dose they should take, not whether or not it has any value. High dose over-the-counter biotin supplements (≥ 5 mg/day,

After 23 years, a syndrome converted me into an eflornithine believer

By Warren R. Heymann, MD, FAAD July 12, 2023 Vol. 5, No. 28 I learned that Vaniqa (eflornithine - ... α -difluoromethylornithine [DFMO]) was discontinued. Topical eflornithine was released in 2000 to reduce facial hirsutism. When the drug was released, I recall being fascinated by the premise of its mechanism.

Coming clean on chlorhexidine-induced dermatoses

By Warren R. Heymann, MD, FAAD March 13, 2024 Vol. 6, No. 11 Dermatologic surgeons use a variety of products that may cause an irritant or allergic contact dermatitis, including antiseptics, anesthetics, gloves, suture materials, tissue adhesives, topical antibiotics, and bandages. Antiseptic agents are the most frequent cause of contact

Acne necrotica: A real head-scratcher

By Warren R. Heymann, MD, FAAD May 15, 2024 Vol. 6, No. 20 I sympathize with new residents in dermatology coming to grips with difficult terms and concepts that are essential in practice. As a novice, I recall struggling with the concept of acne necrotica (AN), dreading that I would

The intimate dance of Staphylococcus aureus and cutaneous T-cell lymphoma

By Warren R. Heymann, MD, FAAD July 19, 2023 Vol. 5, No. 29 I was aghast when I opened the PUVA unit when Joe told me that his mycosis fungoides (MF) was worsening — I understood why Alibert first described the disorder as resembling mushrooms in 1806. (1) His lesions

Bowel-associated dermatosis-arthritis syndrome (BADAS): The story behind the acronym

By Warren R. Heymann, MD, FAAD March 30, 2022 Vol. 4, No. 13 Justifiably, the COVID-19 pandemic has focused the world’s attention, however, another global pandemic threatens us — obesity. According to the World Health Organization, in 2016, more than 1.9 billion people are overweight (BMI > 25) and 650

The pressure to prevent pressure ulcers

By Warren R. Heymann, MD, FAAD Aug. 24, 2022 Vol. 4, No. 34 Pressure ulcers (PUs, aka decubitus ulcers, pressure sores, bed sores) are due to prolonged pressure, characteristically over bony prominences such as the sacrum, occiput, ischial tuberosities, greater trochanters, heels, and lateral malleoli. (1,2) Interestingly, in the COVID-19

Till death do us part: Love, marriage, and cutaneous oncology

By Warren R. Heymann, MD, FAAD April 9, 2025 Vol. 7, No. 14 "What’s that on your back?" ... My wife asked me that question a year after finding a tick at the same site. This time, the dark lesion was a thin melanoma. I hadn’t a clue that a

PS-Dermatology Workforce Diversity and Health Disparities

Vyas DA, Eisenstein LG, Jones DS.

March 20, 2023 AAD/A Board of Directors agenda

Resort & Spa, Itasca, IL 2024 Innovation Academy – August 1-4, 2024 (Thurs – Sun) Seattle, WA

Agenda of the July 23, 2022 AAD/A Board of Directors meeting.

600 PM – 9:00 PM (Central) 2024 Innovation Academy Meeting – Seattle, WA

Promising therapeutic developments for cutaneous lupus erythematosus: Interfering with interferon

By Warren R. Heymann, MD, FAAD Aug. 17, 2022 Vol. 4, No. 33 Disfigurement due to scars and dyspigmentation complicating discoid lupus erythematosus (DLE) can be devastating. The cornerstones of therapy for cutaneous lupus erythematosus (CLE) are steroids (topical, intralesional, systemic) and antimalarials (hydroxychloroquine, chloroquine, quinacrine). Secondary agents include immunosuppressive

Necrobiosis lipoidica in a Wink

By Warren R. Heymann, MD, FAAD May 3, 2023 Vol. 5, No. 18 Ninety years have transpired since Urbach coined the term ... necrobiosis lipoidica diabeticorum (NLD) for the granulomatous disorder first described by Oppenheim in 1929 as ... dermatitis atrophicans lipoidica diabetica . (1) Early authors observed sclerotic plaques

For the win! Championing the use of the term “reactive granulomatous dermatitis” in clinical practice

By David A. Wetter, MD, FAAD March 8, 2023 Vol. 5, No. 10 Growing up in the 1980s in suburban St. Louis, Missouri, I spent many evenings listening to Cardinals’ baseball on the local AM radio station, KMOX 1120. After the final out of each Cardinals’ victory, the late Hall-of-Fame

Pancreatic panniculitis: Getting spooked by ghost cells

By Warren R. Heymann, MD, FAAD July 24, 2024 Vol. 6, No. 30 I am at the age where the diagnosis of pancreatic cancer is a looming fear, punctuated by the loss of my dear aunt Helen and two friends who have succumbed to the ravages of this vicious malignancy.

Malignant syphilis: History in the making

By Warren R. Heymann, MD, FAAD Jan. 3, 2024 Vol. 6, No. 1 As our new academic year commences, soon I will remind our new residents of Sir William Osler's famous aphorism, "He who knows syphilis knows medicine." As the great mimicker, our trainees will never go astray by including

The 21st Century Cures Act: What a difference a day makes

By Warren R. Heymann, MD, FAAD Sept. 24, 2025 Vol. 7, No. 38 The 21st Century Cures Act (Cures Act, CA) was signed into law on Dec. 13, 2016. (1) In April 2021, the Information Blocking Rule (IBR) of the CA went into effect, giving patients immediate access to notes,

Can tocilizumab deep six recalcitrant morphea?

By Warren R. Heymann, MD, FAAD Sept. 20, 2023 Vol. 5, No. 38 Glenda’s middle-aged ankles still hurt badly. I have been treating morphea enveloping her ankles for several years. With therapies including methotrexate, mycophenolate mofetil, clobetasol, calcipotriene, and physical therapy, her tenderness has improved from exquisite to barely tolerable.

The aryl hydrocarbon receptor: Tapinarof is taking off

By Warren R. Heymann, MD, FAAD Nov. 19, 2025 Vol. 7, No. 46 In his outstanding lecture identifying drivers of lupus, presented at the 2025 meeting of the Medical Dermatology Society, Jaehyuk Choi MD, PhD, explained that interferon — the well-known nemesis of lupus — controls the production of T

The nexus of VEXAS syndrome

By Warren R. Heymann, MD, FAAD December 1, 2021 Vol. 3, No. 47 You may not be familiar with VEXAS (Vacuoles, E1 enzyme, X-linked, Autoinflammatory, Somatic) syndrome, but it is conceivable that you have already unknowingly encountered patients with the disorder. ... To appreciate the clinical nuances of the VEXAS

Triskaidekaphobia legitimized: Fatal Factor XIII deficiency

By Warren R. Heymann, MD, FAAD April 12, 2023 Vol. 5, No. 15 I am not especially superstitious. The number 13 has never concerned me but acquired Factor XIII deficiency has now joined my ever-expanding pantheon of new complications to worry about. ... The article entitled "Association of lethal acquired

Hoops and happiness: Having the courage to take a shot

By David A. Wetter, MD March 17, 2021 Vol. 3, No. 11 In dermatology our daily routine is dominated by caring for patients, many of whom have complex diseases that are difficult to manage. Our dedication to help our patients initially drew many of us to the medical profession (and

AAD Innovation Academy 2020 Technical Exhibitor Prospectus

Friday. 70 Pike St., Seattle, WA 98101 Welcome Reception (Exhibits Open) 3 Thursday, August 13 ......

PDF of the Academy position on appropriate use of parrafin sections with Mohs

replace the work of Mohs surgery. 2 Novis DA

Cosmetic complications

Dermatologists offer insight and instruction for approaching procedural afflictions. ... Feature ... By Laura Vernaci, Contributing Writer, September 1, 2025 It goes without saying that dermatologists do everything in their power to keep their patients safe and avoid complications or adverse events. However, stay in the business long enough and

Advances in pruritus therapeutics: It’s Greek to us

By Warren R. Heymann, MD, FAAD June 19, 2024 Vol. 6, No. 25 Every dermatologist encounters maddeningly pruritic patients at their wit’s end. Our deficient understanding of and treating dermatology’s essential symptom is even more exasperating. The following is the abstract from the incisive article by Vander Does et al,

The profound dermatological manifestations of COVID-19 Part VI: Going to the dogs

By Warren R. Heymann, MD July 29, 2020 Vol. 2, No. 30 Disclaimers: This commentary was written on July 12, 2020 for a publication date of July 29, 2020. The issues related to the COVID-19 pandemic are changing rapidly. The content included in this commentary may no longer be factual

Sweet Sounds of the “SKINphony”: Incorporating Music into Daily Dermatologic Practice

By David A. Wetter, MD, FAAD Nov. 29, 2023 Vol. 5, No. 47 It is amazing how music instantaneously transports us back in time. For me, Kool & The Gang’s catchy tune " ... Celebration " ( ... "Celebrate good times, come on!") hearkens back to the 1980s when my

Becoming “sensitized” to the clinical utility of the term “urticarial dermatitis” (a subtype of the dermal hypersensitivity reaction pattern)

By David A. Wetter, MD, FAAD April 2, 2025 Vol. 7, No. 13 I suspect many of us have been confounded when confronted with a patient presenting with cutaneous findings suggestive of a "dermal hypersensitivity reaction." What is the cause? How should it be evaluated and treated? What do we

Agenda for the Nov. 5, 2022 meeting of the AAD and AADA Board of Directors meetings.

6:00 PM – 9:00 PM (Central) 2024 Innovation Academy Meeting – Seattle, WA

Deeper thoughts about acne keloidalis nuchae

DermWorld Insights and Inquiries ... By Warren R. Heymann, MD, FAAD, February 1, 2026 Vol. 8, No. 2 Wallace Clark taught me the truism that thinking often ceases when a diagnosis is rendered. The clinical diagnosis of acne keloidalis nuchae (AKN) is straightforward. Embarrassingly, I had not given much thought

Caveat mTOR revisited: Neurofibromatosis

By Warren R. Heymann, MD, FAAD Feb. 14, 2024 Vol. 6, No. 7 An abridged version of this commentary was published in "A Clinician's Perspective" in the April 2023 issue of the JAAD. ... It is understandable how dermatologists may forget about many details of rare genodermatoses after taking their

The treatment of systemic juvenile xanthogranulomas matures

By Warren R. Heymann, MD, FAAD Jan. 8, 2025 Vol. 7, No. 1 Diagnosing juvenile xanthogranulomas (JXG) is simultaneously satisfying and slightly disconcerting. JXG’s clinical yellow appearance, the "setting sun" on dermoscopy, or the recognition of Touton giant cells histologically allows dermatologists to be reasonably confident of the diagnosis. It

Working up pernio: How far should you dip your toe in the water?

By David A. Wetter, MD May 6, 2020 Vol. 2, No. 18 Dermatologists are rapidly becoming reacquainted with pernio (chilblains), given the increasing reports of pernio-like acral eruptions (and other dermatologic manifestations) occurring in association with COVID-19. (1, 2) This raises an important clinical question: under normal (non-COVID-19) circumstances, what

We’re in hot water! Vibrio vulnificus infections are heading north

By Warren R. Heymann, MD Dec. 16, 2020 Vol. 2, No. 49 When driving to work, I usually listen to our local 24-hour news station, paying half-attention as I’m mentally sorting out the upcoming day’s agenda. Upon hearing a report of several cases ... Vibrio vulnificus (Vv) at my hospital

Skin conditions by the numbers

Acne ... Acne is the most common skin condition in the United States, affecting up to 50 million Americans annually. (1) ... There are different types of acne (blackheads, whiteheads, pimples, acne cysts or nodules), so a one-size-fits-all approach is not the best way to achieve clearer skin. (2) A

Turning a blind eye on second opinions

By Warren R. Heymann, MD, FAAD June 21, 2023 Vol. 5, No. 25 Whenever I encounter patients who ask for, or are being seen for, second opinions, I silently chuckle at Henny Youngman’s timeless one-liner about the subject (you can Google it). The fact is that second opinions are no

PDF of resident & fellows abstract

Lewis DA, Travers JB, and Spandau DF.

PDF of member ethics resources

Grabell DA, Hebert AA. The case of the dog and the blue light.

Professionalism and Ethics

Ethics and medicine have been intertwined since the dawn of our profession. From the ancient Hippocratic Oath to the principle of ... primum non nocere to modern-day principlism, medical ethics have evolved over time. ... As public and professional interest in medical ethics increases, it is important for clinicians, researchers,

Search

Filters

Content Filters

Content Type